Accessibility: Skip TopNav
Qualigen Therapeutics, Inc.
F3-8-60 is active in vivo against pancreatic cancer models
Format
PNG
Quelle:
Qualigen Therapeutics, Inc.
Downloads
Originalgröße
Groß
Mittel
Klein